Related Experiment Videos
Andrea Vitagliano1, Marzia Bonfanti1, Chiara Lucchetti1
1PharmaLex Italy S.p.A., Milano - Italy.
Global & Regional Health Technology Assessment
|April 1, 2025
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Closing the first wave of drug innovativeness in italy: final evidence from 2017 to 2025.
The European journal of health economics : HEPAC : health economics in prevention and care·2026
Impact of Ministerial Decree 77/2022 from different stakeholders' perspectives: clinicians, pharmacists, patients, and industry.
Global & regional health technology assessment·2026
Optimizing CAR-T therapy delivery in the Italian healthcare system: economic and organizational insights in follicular lymphoma.
Global & regional health technology assessment·2026
Assessing the Impact on Health and Productivity Outcomes of Anti-PD-(L)1 Agents to Treat Early-Stage Cancers in Italy.
Clinical drug investigation·2026
[Therapeutic switch from liquid oxygen to oxygen concentrators in the Turin City Local Health Authority: results of the COMBO Project.]
Recenti progressi in medicina·2026
Integrating MCDA and economic evaluation into a rule-based framework for hospital-level health technology assessment.
Global & regional health technology assessment·2026
Burden of primary biliary cholangitis on the Italian National Health Service: retrospective analysis from an administrative database.
Global & regional health technology assessment·2026
Pharmacoeconomic analysis of switch to faricimab for neovascular age-related macular degeneration in real clinical practice.
Global & regional health technology assessment·2026
Impact of AIFA Note 100 on innovative antidiabetic prescribing eligibility in two Italian local health authorities: drug utilization and patient characteristics.
Global & regional health technology assessment·2026
Procedural activity and dynamics of the new Italian Scientific and Economic Committee (CSE): a one-year observational analysis.
Global & regional health technology assessment·2026
Dynamic Emissions and Secondary Organic Aerosol Formation from Real Personal Care Products: New Insights into Siloxane-Containing Molecules.
Environmental science & technology·2026
Defining 'psychedelic'.
Journal of psychopharmacology (Oxford, England)·2026
Fragment Molecular Orbital Drug Design Consortium (FMODD): Bridging Academia and Industry Through Prospective FMO-Driven Drug Design.
Methods in molecular biology (Clifton, N.J.)·2026
Oxalate and oxalotrophy: an environmental perspective.
Sustainable microbiology·2026